Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » coronavirus

coronavirus

Breaking news on coronavirus testing, with real-time reporting on assays to detect the SARS-CoV2 coronavirus, which causes COVID-19. 

Check out our Coronavirus Test Tracker for the latest information on the regulatory status of these tests in the US, European, and Asian markets.

Jan 21, 2021

Fluidigm Obtains CE Mark for Saliva-Based SARS-CoV-2 Assay

Fluidigm's Advanta Dx SARS-CoV-2 RT-PCR assay is an extraction-free saliva-based test to detect nucleic acid from the SARS-CoV-2 virus.

Jan 21, 2021

US to Remain in WHO

Anthony Fauci also informed the World Health Organization executive board that the US would be joining the COVAX initiative, according to CNBC.

Jan 21, 2021

Dip Possible

A new preprint suggests some SARS-CoV-2 variants could affect the effectiveness of current vaccines, the Associated Press reports.

Jan 20, 2021

California Strain

The New York Times reports that Cedars-Sinai researchers have uncovered a new strain of SARS-CoV-2 in Southern California.

Jan 20, 2021

Boosting Viral Surveillance

The Financial Times reports the US bolstering its ability to track SARS-CoV-2 alterations.

Jan 20, 2021

Bio-Rad, United Biomedical Get FDA Emergency Use Authorizations for Coronavirus Tests

Bio-Rad's PCR-based test is designed to detect SARS-CoV-2 nucleic acid, while United Biomedical's test detects antibodies against the virus.

Jan 19, 2021

What's It Called?

Nature News writes that scientists are trying to figure out how to name the new strains of SARS-CoV-2 that are emerging.

Jan 19, 2021

Twin COVID-19 Studies

The New York Times reports that researchers are studying identical twins who had COVID-19 to understand the influence of genetics on disease severity.

Jan 19, 2021

Quest Diagnostics Wins CDC Contract to Sequence SARS-CoV-2 Samples

The work is part of a CDC project to identify novel mutations in the virus and better understand its prevalence and patterns of transmission throughout the US.

Jan 19, 2021

Thermo Fisher Scientific to Acquire Mesa Biotech for Up to $550M

The firm sells a rapid, point-of-care, PCR platform for infectious disease diagnostics, including SARS-CoV-2, influenza, respiratory syncytial virus, and strep A.

Pages

The Scan

Open Spot

Politico notes that the Biden Administration has not yet nominated a permanent Food and Drug Administration commissioner. 

US to Remain in WHO

Anthony Fauci also informed the World Health Organization executive board that the US would be joining the COVAX initiative, according to CNBC.

Dip Possible

A new preprint suggests some SARS-CoV-2 variants could affect the effectiveness of current vaccines, the Associated Press reports.

Nature Papers Examine Australian Lungfish Genome, Essential E. Coli Genes

In Nature this week: Australian lungfish provides details on the movement of vertebrate life from water to land, and more.

What's Popular?

In coronavirus

  1. Lucira Health Files for $115M IPO

  2. Thermo Fisher Scientific to Acquire Mesa Biotech for Up to $550M

  3. Quest Diagnostics Wins CDC Contract to Sequence SARS-CoV-2 Samples

  4. Bio-Rad, United Biomedical Get FDA Emergency Use Authorizations for Coronavirus Tests

  5. Fluidigm Obtains CE Mark for Saliva-Based SARS-CoV-2 Assay

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.